85-1384-88 NOS III, Control Peptide (Endothelial Nitric Oxide Synthase, eNOS, NOS 3) 100ug N5350-28A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Control peptide for Inducible Nitric Oxide Synthase (iNOS, iNOS 2, mNOS) cat#s: N5350-28, N5350-28B, N5350-29.
  • 15 amino acid peptide sequence corresponding to human eNOS. Human, rat, mouse and bovine eNOS/NOS-3 are ~1202-1205aa proteins
  • Corresponding antibody recognizes the 135-140kD protein endothelial nitric oxide synthase (eNOS, NOS III). Sequence is 100% conserved in mouse/bovine (15/15 aa), 93% in rat (14/15 aa) and 86% in pig (13/15 aa). No significant sequence homology is seen with NOS-1/NOS-2 or other proteins.
  • Nitric oxide (NO), a diffusible free radical gas, acts as a neurotransmitter in brain and peripheral nervous system. It accounts for the activity of endothelium-derived relaxing factors, which stimulate vasodilatation by releasing NO from the endothelium. Unlike typical neurotransmitter, NO is a not stored in synaptic vesicle and does not act on membrane receptors. Synthesis of NO, initially demonstrated in vascular endothelium, is now found in many tissues.
  • NO is synthesized by L-arginine, oxygen, and NADPH by three known isoforms of heme-containing flavoproteins termed NO synthase (NOS, I-III, mol wt. ~130-160kD). One group of enzyme is constitutive, agonist-triggered, and dependent on Ca2+/Calmodulin and is inhibited by L-arginine analogues (L-NNA, L-NMMA). It is found in endothelium, adrenal glands, brain and platelets. The other principle group is inducible, Ca2+/Calmodulin-independent, and inhibited by NMMA and L-NNA. It has been found in macrophage, hepatocytes, tumor cells, vascular smooth muscle and endothelial cells. Analyses of cDNA clones have identified three distinct NOS genes in mammals: neuronal (nNOS/bNOS/NOS-I), endothelial (eNOS/NOS-III), and macrophage (mNOS/iNOS/NOS-II). Both nNOS and eNOS are constitutive and the mNOS/iNOS is inducible. Sequence homology among different cloned isoforms is ~ 50%.
  • Applications:Suitable for use in ELISA, Western Blotting. Other applications not tested.
  • Recommended Dilution:ELISA: Control peptide should be coated at 1ug/ml
  • Western Blotting: 1:100-1:1000. Recognizes 135-140kD protein
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:100ug
  • Grade:Purified
  • Purity:Purified
  • Form:Supplied as a lyophilized powder from PBS, 0.05% sodium azide.
  • Calc Applications Abbrev:E
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1384-88
型番
N5350-28A
入り数
1個
標準価格
130,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る